California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on July 22, 2026

Jul. 22, 2026

Avalo Therapeutics to Participate in the BTIG Biotechnology Conference

Indeterminate GlobeNewswire

Jul. 22, 2026

Geron Plans to Announce Second Quarter 2026 Financial Results on August 5, 2026

Indeterminate GlobeNewswire

Jul. 22, 2026

BioCryst to Report Second Quarter 2026 Financial Results on August 5

Indeterminate GlobeNewswire

Jul. 22, 2026

Lungpacer Announces New Category III CPT® Codes for AeroPace® Diaphragm Neurostimulation Therapy

Indeterminate GlobeNewswire

Jul. 22, 2026

OKYO Pharma Announces Purchase of Shares by Chief Medical Officer

Indeterminate GlobeNewswire

Jul. 22, 2026

Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman

Indeterminate GlobeNewswire

Jul. 22, 2026

Publication in Clinical Reviews in Allergy & Immunology Summarizes Decades of Evidence Supporting Bradykinin B2 Receptor as a Validated Therapeutic Target in Bradykinin-Mediated Angioedema

Indeterminate GlobeNewswire

Jul. 22, 2026

Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026

Indeterminate GlobeNewswire

Jul. 22, 2026

Bunzl Canada Surpasses $2M Raised for Pediatric Brain Tumour Research

Indeterminate GlobeNewswire

Jul. 22, 2026

RadNet, Inc. Announces Date of its Second Quarter 2026 Financial Results Conference Call

Indeterminate GlobeNewswire

Jul. 22, 2026

Bunzl Canada dépasse les 2 M$ amassés pour la recherche sur les tumeurs cérébrales pédiatriques

Indeterminate GlobeNewswire

Jul. 22, 2026

Supportive Cancer Care Takes Center Stage as Members of the National Coalition Together for Supportive Cancer Care Ring the Nasdaq Closing Bell

Indeterminate GlobeNewswire

Jul. 22, 2026

Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media

Indeterminate GlobeNewswire

Jul. 22, 2026

Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom

Indeterminate GlobeNewswire

Jul. 22, 2026

Acentra Health Appoints Sreedevi Hegde as Senior Vice President – India Country Head

Indeterminate GlobeNewswire

Jul. 22, 2026

Genenta-Backed Sòphia High Tech Reports Fiscal Year 2025 Results

Indeterminate GlobeNewswire

Jul. 22, 2026

ReBio Pharma appoints leading ocular oncologist Professor Mandeep Sagoo as Chief Medical Officer

Indeterminate GlobeNewswire

Jul. 22, 2026

Healx Announces First Patient Dosed in Phase 1/2 Trial to Evaluate the Effect of HLX-4310 on Metastatic Recurrence and Progression in Sarcomas with a Focus on Osteosarcoma

Indeterminate GlobeNewswire

Jul. 22, 2026

Ipsen completes acquisition of Memo Therapeutics AG, adding first-in-class asset to Ipsen's Rare Disease pipeline

Indeterminate GlobeNewswire

Jul. 22, 2026

Ipsen finalise l'acquisition de Memo Therapeutics AG, ajoutant un actif premier de sa classe au portefeuille de maladies rares d'Ipsen

Indeterminate GlobeNewswire